BioSpace News Archive

Heska announced today the release of the new Element COAG Veterinary Analyzer.

Xencor announced that it will release third quarter 2017 financial results after the market closes on Tuesday, November 7, 2017.

RegeneRx today announced the results of its phase III dry eye trial sponsored by its U.S. joint venture, ReGenTree, LLC.

Currently, there are 57 active clinical trials underway, funded by Gateway at such esteemed institutions as Children’s Hospital of Philadelphia, Columbia University, Duke University, Johns Hopkins University, Mayo Clinic, MD Anderson and Memorial Sloan Kettering, as well as cancer centers in four other countries.

Ocular Therapeutix today announced that it will report third quarter 2017 financial results on Tuesday, November 7, 2017.

The appointment of Dr. Lanman replaces outgoing director Fredrick H. Moll, M.D., who is resigning from the Board effective November 11, 2017, due to his commitments associated with his role as CEO of Auris Surgical Robotics, Inc.

The meeting consisted of a general discussion of issues identified by the FDA after the first 100 days of regulatory review and suggestions for clarification of those issues.

The research will be conducted at a laboratory at the University of Florida’s McKnight Brain Institute focused on neurotrauma, neuroproteomics and biomarkers research headed by Wang.